BioCentury | Jan 22, 2015
Distillery Therapeutics

Therapeutics: Bacterial lipid II; bacterial lipid III

...III LICENSING STATUS: Patent issued to Northeastern University; licensed to Novobiotic Pharmaceuticals LLC; multiple patents filed by Novobiotic...
BioCentury | Jan 22, 2015
Targets & Mechanisms

Unearthing antibiotics

...importance for the field. Teixobactin was discovered by researchers at Northeastern University in collaboration with NovoBiotic Pharmaceuticals LLC...
...and been unable to grow any new soil organisms in culture. Using different approaches, the Northeastern-Novobiotic...
...that was previously unculturable. The culturing system is owned by Northeastern and licensed to Novobiotic...
BioCentury | Jan 9, 2015
Company News

Researchers identify novel antibiotics in dirt

...University and the University of Bonn collaborated with NovoBiotic on the study. Kim Lewis, a NovoBiotic...
...in a way that would modify not only one but two different precursors," he said. NovoBiotic...
...take teixobactin into clinical testing while simultaneously creating analogues with improved pharmacological properties. Kim said NovoBiotic...
Items per page:
1 - 3 of 3
BioCentury | Jan 22, 2015
Distillery Therapeutics

Therapeutics: Bacterial lipid II; bacterial lipid III

...III LICENSING STATUS: Patent issued to Northeastern University; licensed to Novobiotic Pharmaceuticals LLC; multiple patents filed by Novobiotic...
BioCentury | Jan 22, 2015
Targets & Mechanisms

Unearthing antibiotics

...importance for the field. Teixobactin was discovered by researchers at Northeastern University in collaboration with NovoBiotic Pharmaceuticals LLC...
...and been unable to grow any new soil organisms in culture. Using different approaches, the Northeastern-Novobiotic...
...that was previously unculturable. The culturing system is owned by Northeastern and licensed to Novobiotic...
BioCentury | Jan 9, 2015
Company News

Researchers identify novel antibiotics in dirt

...University and the University of Bonn collaborated with NovoBiotic on the study. Kim Lewis, a NovoBiotic...
...in a way that would modify not only one but two different precursors," he said. NovoBiotic...
...take teixobactin into clinical testing while simultaneously creating analogues with improved pharmacological properties. Kim said NovoBiotic...
Items per page:
1 - 3 of 3